• Photo of Arthur Caplan

    Arthur L. Caplan, PhD

    Drs. William F. and Virginia Connolly Mitty Professor & Head, Division of Bioethics, New York University Langone Medical Center
  • Photo of Kenneth Getz

    Kenneth A. Getz, MBA

    Founder and Chairman, CISCRP; Professor, Center for the Study of Drug Development, Tufts University School of Medicine
  • Photo of Scott Hayworth

    Scott Hayworth, MD

    President, Optum Tri-State Region and CEO, CareMount Health Solutions; Senior Advisor and Advisory Board Member, Arsenal Capital Partners
  • Photo of Sir William Castell

    Sir William Castell

    Senior Advisor, Arsenal Capital Partners; Previously President & Chief Executive Officer, GE Healthcare

The WCG Oncology Advisory Board is made up of thought-leaders in oncology who provide WCG with guidance and strategic counsel on the changing landscape of research in oncology.

The WCG Gene Therapy Advisory Board provides guidance and strategic counsel to WCG and our clients, ensuring that knowledge and best practices are reflected in the company’s oversight of human gene transfer research, which involves the careful coordination of institutional review board (IRB) and institutional biosafety committee (IBC) reviews.

The CNS Scientific Leadership Team reflects multiple specialties within the therapeutic area of central nervous system (CNS). The specialists provide expert guidance to WCG’s clients, while also supporting the design and execution of WCG’s technology-enabled solutions applied to clinical trials in neurodegenerative and behavioral health disorders.